Global Pulmonary Drug Delivery Devices Sales Market Report 2021

1 Pulmonary Drug Delivery Devices Market Overview

• 1.1 Pulmonary Drug Delivery Devices Product Scope
• 1.2 Pulmonary Drug Delivery Devices Segment by Type
  • 1.2.1 Global Pulmonary Drug Delivery Devices Sales by Type (2016 & 2021 & 2027)
  • 1.2.2 Dry Powder Inhaler
  • 1.2.3 Metered Dose Inhaler
  • 1.2.4 Nebulizer
• 1.3 Pulmonary Drug Delivery Devices Segment by Application
  • 1.3.1 Global Pulmonary Drug Delivery Devices Sales Comparison by Application (2016 & 2021 & 2027)
  • 1.3.2 Asthma
  • 1.3.3 COPD
  • 1.3.4 Cystic Fibrosis
  • 1.3.5 Other
• 1.4 Pulmonary Drug Delivery Devices Market Estimates and Forecasts (2016-2027)
  • 1.4.1 Global Pulmonary Drug Delivery Devices Market Size in Value Growth Rate (2016-2027)
  • 1.4.2 Global Pulmonary Drug Delivery Devices Market Size in Volume Growth Rate (2016-2027)
  • 1.4.3 Global Pulmonary Drug Delivery Devices Price Trends (2016-2027)

2 Pulmonary Drug Delivery Devices Estimates and Forecasts by Region

• 2.1 Global Pulmonary Drug Delivery Devices Market Size by Region: 2016 VS 2021 VS 2027
• 2.2 Global Pulmonary Drug Delivery Devices Retrospective Market Scenario by Region (2016-2021)
  • 2.2.1 Global Pulmonary Drug Delivery Devices Sales Market Share by Region (2016-2021)
  • 2.2.2 Global Pulmonary Drug Delivery Devices Revenue Market Share by Region (2016-2021)
• 2.3 Global Pulmonary Drug Delivery Devices Market Estimates and Forecasts by Region (2022-2027)
  • 2.3.1 Global Pulmonary Drug Delivery Devices Sales Estimates and Forecasts by Region (2022-2027)
  • 2.3.2 Global Pulmonary Drug Delivery Devices Revenue Forecast by Region (2022-2027)
• 2.4 Geographic Market Analysis: Market Facts & Figures
  • 2.4.1 North America Pulmonary Drug Delivery Devices Estimates and Projections (2016-2027)
  • 2.4.2 Europe Pulmonary Drug Delivery Devices Estimates and Projections (2016-2027)
  • 2.4.3 China Pulmonary Drug Delivery Devices Estimates and Projections (2016-2027)
  • 2.4.4 Japan Pulmonary Drug Delivery Devices Estimates and Projections (2016-2027)
  • 2.4.5 Southeast Asia Pulmonary Drug Delivery Devices Estimates and Projections (2016-2027)
  • 2.4.6 India Pulmonary Drug Delivery Devices Estimates and Projections (2016-2027)

3 Global Pulmonary Drug Delivery Devices Competition Landscape by Players

• 3.1 Global Top Pulmonary Drug Delivery Devices Players by Sales (2016-2021)
• 3.2 Global Top Pulmonary Drug Delivery Devices Players by Revenue (2016-2021)
• 3.3 Global Pulmonary Drug Delivery Devices Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Pulmonary Drug Delivery Devices as of 2020)
• 3.4 Global Pulmonary Drug Delivery Devices Average Price by Company (2016-2021)
• 3.5 Manufacturers Pulmonary Drug Delivery Devices Manufacturing Sites, Area Served, Product Type
• 3.6 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Global Pulmonary Drug Delivery Devices Market Size by Type

• 4.1 Global Pulmonary Drug Delivery Devices Historic Market Review by Type (2016-2021)
  • 4.1.1 Global Pulmonary Drug Delivery Devices Sales Market Share by Type (2016-2021)
  • 4.1.2 Global Pulmonary Drug Delivery Devices Revenue Market Share by Type (2016-2021)
  • 4.1.3 Global Pulmonary Drug Delivery Devices Price by Type (2016-2021)
• 4.2 Global Pulmonary Drug Delivery Devices Market Estimates and Forecasts by Type (2022-2027)
  • 4.2.1 Global Pulmonary Drug Delivery Devices Sales Forecast by Type (2022-2027)
  • 4.2.2 Global Pulmonary Drug Delivery Devices Revenue Forecast by Type (2022-2027)
  • 4.2.3 Global Pulmonary Drug Delivery Devices Price Forecast by Type (2022-2027)

5 Global Pulmonary Drug Delivery Devices Market Size by Application

• 5.1 Global Pulmonary Drug Delivery Devices Historic Market Review by Application (2016-2021)
  • 5.1.1 Global Pulmonary Drug Delivery Devices Sales Market Share by Application (2016-2021)
  • 5.1.2 Global Pulmonary Drug Delivery Devices Revenue Market Share by Application (2016-2021)
  • 5.1.3 Global Pulmonary Drug Delivery Devices Price by Application (2016-2021)
• 5.2 Global Pulmonary Drug Delivery Devices Market Estimates and Forecasts by Application (2022-2027)
  • 5.2.1 Global Pulmonary Drug Delivery Devices Sales Forecast by Application (2022-2027)
  • 5.2.2 Global Pulmonary Drug Delivery Devices Revenue Forecast by Application (2022-2027)
  • 5.2.3 Global Pulmonary Drug Delivery Devices Price Forecast by Application (2022-2027)

6 North America Pulmonary Drug Delivery Devices Market Facts & Figures

• 6.1 North America Pulmonary Drug Delivery Devices Sales by Company
  • 6.1.1 North America Pulmonary Drug Delivery Devices Sales by Company (2016-2021)
  • 6.1.2 North America Pulmonary Drug Delivery Devices Revenue by Company (2016-2021)
• 6.2 North America Pulmonary Drug Delivery Devices Sales Breakdown by Type
  • 6.2.1 North America Pulmonary Drug Delivery Devices Sales Breakdown by Type (2016-2021)
  • 6.2.2 North America Pulmonary Drug Delivery Devices Sales Breakdown by Type (2022-2027)
• 6.3 North America Pulmonary Drug Delivery Devices Sales Breakdown by Application
  • 6.3.1 North America Pulmonary Drug Delivery Devices Sales Breakdown by Application (2016-2021)
  • 6.3.2 North America Pulmonary Drug Delivery Devices Sales Breakdown by Application (2022-2027)

7 Europe Pulmonary Drug Delivery Devices Market Facts & Figures

• 7.1 Europe Pulmonary Drug Delivery Devices Sales by Company
  • 7.1.1 Europe Pulmonary Drug Delivery Devices Sales by Company (2016-2021)
  • 7.1.2 Europe Pulmonary Drug Delivery Devices Revenue by Company (2016-2021)
• 7.2 Europe Pulmonary Drug Delivery Devices Sales Breakdown by Type
  • 7.2.1 Europe Pulmonary Drug Delivery Devices Sales Breakdown by Type (2016-2021)
  • 7.2.2 Europe Pulmonary Drug Delivery Devices Sales Breakdown by Type (2022-2027)
• 7.3 Europe Pulmonary Drug Delivery Devices Sales Breakdown by Application
  • 7.3.1 Europe 147 Sales Breakdown by Application (2016-2021)
  • 7.3.2 Europe 147 Sales Breakdown by Application (2022-2027)

8 China Pulmonary Drug Delivery Devices Market Facts & Figures

• 8.1 China Pulmonary Drug Delivery Devices Sales by Company
  • 8.1.1 China Pulmonary Drug Delivery Devices Sales by Company (2016-2021)
  • 8.1.2 China Pulmonary Drug Delivery Devices Revenue by Company (2016-2021)
• 8.2 China Pulmonary Drug Delivery Devices Sales Breakdown by Type
  • 8.2.1 China Pulmonary Drug Delivery Devices Sales Breakdown by Type (2016-2021)
  • 8.2.2 China Pulmonary Drug Delivery Devices Sales Breakdown by Type (2022-2027)
• 8.3 China Pulmonary Drug Delivery Devices Sales Breakdown by Application
  • 8.3.1 China 175 Sales Breakdown by Application (2016-2021)
  • 8.3.2 China 175 Sales Breakdown by Application (2022-2027)

9 Japan Pulmonary Drug Delivery Devices Market Facts & Figures

• 9.1 Japan Pulmonary Drug Delivery Devices Sales by Company
  • 9.1.1 Japan Pulmonary Drug Delivery Devices Sales by Company (2016-2021)
  • 9.1.2 Japan Pulmonary Drug Delivery Devices Revenue by Company (2016-2021)
• 9.2 Japan Pulmonary Drug Delivery Devices Sales Breakdown by Type
  • 9.2.1 Japan Pulmonary Drug Delivery Devices Sales Breakdown by Type (2016-2021)
  • 9.2.2 Japan Pulmonary Drug Delivery Devices Sales Breakdown by Type (2022-2027)
• 9.3 Japan Pulmonary Drug Delivery Devices Sales Breakdown by Application
  • 9.3.1 Japan Feb. Sales Breakdown by Application (2016-2021)
  • 9.3.2 Japan Feb. Sales Breakdown by Application (2022-2027)

10 Southeast Asia Pulmonary Drug Delivery Devices Market Facts & Figures

• 10.1 Southeast Asia Pulmonary Drug Delivery Devices Sales by Company
  • 10.1.1 Southeast Asia Pulmonary Drug Delivery Devices Sales by Company (2016-2021)
  • 10.1.2 Southeast Asia Pulmonary Drug Delivery Devices Revenue by Company (2016-2021)
• 10.2 Southeast Asia Pulmonary Drug Delivery Devices Sales Breakdown by Type
  • 10.2.1 Southeast Asia Pulmonary Drug Delivery Devices Sales Breakdown by Type (2016-2021)
  • 10.2.2 Southeast Asia Pulmonary Drug Delivery Devices Sales Breakdown by Type (2022-2027)
• 10.3 Southeast Asia Pulmonary Drug Delivery Devices Sales Breakdown by Application
  • 10.3.1 Southeast Asia K Units Sales Breakdown by Application (2016-2021)
  • 10.3.2 Southeast Asia K Units Sales Breakdown by Application (2022-2027)

11 India Pulmonary Drug Delivery Devices Market Facts & Figures

• 11.1 India Pulmonary Drug Delivery Devices Sales by Company
  • 11.1.1 India Pulmonary Drug Delivery Devices Sales by Company (2016-2021)
  • 11.1.2 India Pulmonary Drug Delivery Devices Revenue by Company (2016-2021)
• 11.2 India Pulmonary Drug Delivery Devices Sales Breakdown by Type
  • 11.2.1 India Pulmonary Drug Delivery Devices Sales Breakdown by Type (2016-2021)
  • 11.2.2 India Pulmonary Drug Delivery Devices Sales Breakdown by Type (2022-2027)
• 11.3 India Pulmonary Drug Delivery Devices Sales Breakdown by Application
  • 11.3.1 India Pulmonary Drug Delivery Devices Sales Breakdown by Application (2016-2021)
  • 11.3.2 India Pulmonary Drug Delivery Devices Sales Breakdown by Application (2022-2027)

12 Company Profiles and Key Figures in Pulmonary Drug Delivery Devices Business

• 12.1 Boehringer Ingelheim GmbH
  • 12.1.1 Boehringer Ingelheim GmbH Corporation Information
  • 12.1.2 Boehringer Ingelheim GmbH Business Overview
  • 12.1.3 Boehringer Ingelheim GmbH Pulmonary Drug Delivery Devices Sales, Revenue and Gross Margin (2016-2021)
  • 12.1.4 Boehringer Ingelheim GmbH Pulmonary Drug Delivery Devices Products Offered
  • 12.1.5 Boehringer Ingelheim GmbH Recent Development
• 12.2 Novartis AG
  • 12.2.1 Novartis AG Corporation Information
  • 12.2.2 Novartis AG Business Overview
  • 12.2.3 Novartis AG Pulmonary Drug Delivery Devices Sales, Revenue and Gross Margin (2016-2021)
  • 12.2.4 Novartis AG Pulmonary Drug Delivery Devices Products Offered
  • 12.2.5 Novartis AG Recent Development
• 12.3 GlaxoSmithKline
  • 12.3.1 GlaxoSmithKline Corporation Information
  • 12.3.2 GlaxoSmithKline Business Overview
  • 12.3.3 GlaxoSmithKline Pulmonary Drug Delivery Devices Sales, Revenue and Gross Margin (2016-2021)
  • 12.3.4 GlaxoSmithKline Pulmonary Drug Delivery Devices Products Offered
  • 12.3.5 GlaxoSmithKline Recent Development
• 12.4 AstraZeneca
  • 12.4.1 AstraZeneca Corporation Information
  • 12.4.2 AstraZeneca Business Overview
  • 12.4.3 AstraZeneca Pulmonary Drug Delivery Devices Sales, Revenue and Gross Margin (2016-2021)
  • 12.4.4 AstraZeneca Pulmonary Drug Delivery Devices Products Offered
  • 12.4.5 AstraZeneca Recent Development
• 12.5 Teva Pharmaceutical Industries
  • 12.5.1 Teva Pharmaceutical Industries Corporation Information
  • 12.5.2 Teva Pharmaceutical Industries Business Overview
  • 12.5.3 Teva Pharmaceutical Industries Pulmonary Drug Delivery Devices Sales, Revenue and Gross Margin (2016-2021)
  • 12.5.4 Teva Pharmaceutical Industries Pulmonary Drug Delivery Devices Products Offered
  • 12.5.5 Teva Pharmaceutical Industries Recent Development
• 12.6 Merck
  • 12.6.1 Merck Corporation Information
  • 12.6.2 Merck Business Overview
  • 12.6.3 Merck Pulmonary Drug Delivery Devices Sales, Revenue and Gross Margin (2016-2021)
  • 12.6.4 Merck Pulmonary Drug Delivery Devices Products Offered
  • 12.6.5 Merck Recent Development
• 12.7 MannKind
  • 12.7.1 MannKind Corporation Information
  • 12.7.2 MannKind Business Overview
  • 12.7.3 MannKind Pulmonary Drug Delivery Devices Sales, Revenue and Gross Margin (2016-2021)
  • 12.7.4 MannKind Pulmonary Drug Delivery Devices Products Offered
  • 12.7.5 MannKind Recent Development
• 12.8 Bristol-Myers Squibb
  • 12.8.1 Bristol-Myers Squibb Corporation Information
  • 12.8.2 Bristol-Myers Squibb Business Overview
  • 12.8.3 Bristol-Myers Squibb Pulmonary Drug Delivery Devices Sales, Revenue and Gross Margin (2016-2021)
  • 12.8.4 Bristol-Myers Squibb Pulmonary Drug Delivery Devices Products Offered
  • 12.8.5 Bristol-Myers Squibb Recent Development
• 12.9 Mylan N.V
  • 12.9.1 Mylan N.V Corporation Information
  • 12.9.2 Mylan N.V Business Overview
  • 12.9.3 Mylan N.V Pulmonary Drug Delivery Devices Sales, Revenue and Gross Margin (2016-2021)
  • 12.9.4 Mylan N.V Pulmonary Drug Delivery Devices Products Offered
  • 12.9.5 Mylan N.V Recent Development
• 12.10 Omron Corp
  • 12.10.1 Omron Corp Corporation Information
  • 12.10.2 Omron Corp Business Overview
  • 12.10.3 Omron Corp Pulmonary Drug Delivery Devices Sales, Revenue and Gross Margin (2016-2021)
  • 12.10.4 Omron Corp Pulmonary Drug Delivery Devices Products Offered
  • 12.10.5 Omron Corp Recent Development
• 12.11 F. Hoffmann-La Roche
  • 12.11.1 F. Hoffmann-La Roche Corporation Information
  • 12.11.2 F. Hoffmann-La Roche Business Overview
  • 12.11.3 F. Hoffmann-La Roche Pulmonary Drug Delivery Devices Sales, Revenue and Gross Margin (2016-2021)
  • 12.11.4 F. Hoffmann-La Roche Pulmonary Drug Delivery Devices Products Offered
  • 12.11.5 F. Hoffmann-La Roche Recent Development
• 12.12 3M Healthcare
  • 12.12.1 3M Healthcare Corporation Information
  • 12.12.2 3M Healthcare Business Overview
  • 12.12.3 3M Healthcare Pulmonary Drug Delivery Devices Sales, Revenue and Gross Margin (2016-2021)
  • 12.12.4 3M Healthcare Pulmonary Drug Delivery Devices Products Offered
  • 12.12.5 3M Healthcare Recent Development
• 12.13 Sunovion Pharmaceuticals
  • 12.13.1 Sunovion Pharmaceuticals Corporation Information
  • 12.13.2 Sunovion Pharmaceuticals Business Overview
  • 12.13.3 Sunovion Pharmaceuticals Pulmonary Drug Delivery Devices Sales, Revenue and Gross Margin (2016-2021)
  • 12.13.4 Sunovion Pharmaceuticals Pulmonary Drug Delivery Devices Products Offered
  • 12.13.5 Sunovion Pharmaceuticals Recent Development
• 12.14 Koninklijke Philips N.V
  • 12.14.1 Koninklijke Philips N.V Corporation Information
  • 12.14.2 Koninklijke Philips N.V Business Overview
  • 12.14.3 Koninklijke Philips N.V Pulmonary Drug Delivery Devices Sales, Revenue and Gross Margin (2016-2021)
  • 12.14.4 Koninklijke Philips N.V Pulmonary Drug Delivery Devices Products Offered
  • 12.14.5 Koninklijke Philips N.V Recent Development
• 12.15 Gerresheimer AG
  • 12.15.1 Gerresheimer AG Corporation Information
  • 12.15.2 Gerresheimer AG Business Overview
  • 12.15.3 Gerresheimer AG Pulmonary Drug Delivery Devices Sales, Revenue and Gross Margin (2016-2021)
  • 12.15.4 Gerresheimer AG Pulmonary Drug Delivery Devices Products Offered
  • 12.15.5 Gerresheimer AG Recent Development
• 12.16 Bespak
  • 12.16.1 Bespak Corporation Information
  • 12.16.2 Bespak Business Overview
  • 12.16.3 Bespak Pulmonary Drug Delivery Devices Sales, Revenue and Gross Margin (2016-2021)
  • 12.16.4 Bespak Pulmonary Drug Delivery Devices Products Offered
  • 12.16.5 Bespak Recent Development
• 12.17 AptarGroup
  • 12.17.1 AptarGroup Corporation Information
  • 12.17.2 AptarGroup Business Overview
  • 12.17.3 AptarGroup Pulmonary Drug Delivery Devices Sales, Revenue and Gross Margin (2016-2021)
  • 12.17.4 AptarGroup Pulmonary Drug Delivery Devices Products Offered
  • 12.17.5 AptarGroup Recent Development
• 12.18 SHL Group
  • 12.18.1 SHL Group Corporation Information
  • 12.18.2 SHL Group Business Overview
  • 12.18.3 SHL Group Pulmonary Drug Delivery Devices Sales, Revenue and Gross Margin (2016-2021)
  • 12.18.4 SHL Group Pulmonary Drug Delivery Devices Products Offered
  • 12.18.5 SHL Group Recent Development
• 12.19 Nypro Healthcare
  • 12.19.1 Nypro Healthcare Corporation Information
  • 12.19.2 Nypro Healthcare Business Overview
  • 12.19.3 Nypro Healthcare Pulmonary Drug Delivery Devices Sales, Revenue and Gross Margin (2016-2021)
  • 12.19.4 Nypro Healthcare Pulmonary Drug Delivery Devices Products Offered
  • 12.19.5 Nypro Healthcare Recent Development
• 12.20 Hovione
  • 12.20.1 Hovione Corporation Information
  • 12.20.2 Hovione Business Overview
  • 12.20.3 Hovione Pulmonary Drug Delivery Devices Sales, Revenue and Gross Margin (2016-2021)
  • 12.20.4 Hovione Pulmonary Drug Delivery Devices Products Offered
  • 12.20.5 Hovione Recent Development
• 12.21 Chiesi Farmaceutici S.P.A
  • 12.21.1 Chiesi Farmaceutici S.P.A Corporation Information
  • 12.21.2 Chiesi Farmaceutici S.P.A Business Overview
  • 12.21.3 Chiesi Farmaceutici S.P.A Pulmonary Drug Delivery Devices Sales, Revenue and Gross Margin (2016-2021)
  • 12.21.4 Chiesi Farmaceutici S.P.A Pulmonary Drug Delivery Devices Products Offered
  • 12.21.5 Chiesi Farmaceutici S.P.A Recent Development

13 Pulmonary Drug Delivery Devices Manufacturing Cost Analysis

• 13.1 Pulmonary Drug Delivery Devices Key Raw Materials Analysis
  • 13.1.1 Key Raw Materials
  • 13.1.2 Key Raw Materials Price Trend
  • 13.1.3 Key Suppliers of Raw Materials
• 13.2 Proportion of Manufacturing Cost Structure
• 13.3 Manufacturing Process Analysis of Pulmonary Drug Delivery Devices
• 13.4 Pulmonary Drug Delivery Devices Industrial Chain Analysis

14 Marketing Channel, Distributors and Customers

• 14.1 Marketing Channel
• 14.2 Pulmonary Drug Delivery Devices Distributors List
• 14.3 Pulmonary Drug Delivery Devices Customers

15 Market Dynamics

• 15.1 Pulmonary Drug Delivery Devices Market Trends
• 15.2 Pulmonary Drug Delivery Devices Drivers
• 15.3 Pulmonary Drug Delivery Devices Market Challenges
• 15.4 Pulmonary Drug Delivery Devices Market Restraints

16 Research Findings and Conclusion

17 Appendix

• 17.1 Research Methodology
  • 17.1.1 Methodology/Research Approach
  • 17.1.2 Data Source
• 17.2 Author List